Protein p130Cas constitutes an adaptor protein mainly involved in integrin signaling downstream of Src kinase. Owing to its modular structure, p130Cas acts as a general regulator of cancer cell growth and invasiveness induced by different oncogenes. However, other mechanisms of p130Cas signaling leading to malignant progression are poorly understood. Here, we show a novel interaction of p130Cas with Ser/Thr kinase PKN3, which is implicated in prostate and breast cancer growth downstream of phosphoinositide 3-kinase. This direct interaction is mediated by the p130Cas SH3 domain and the centrally located PKN3 polyproline sequence. PKN3 is the first identified Ser/Thr kinase to bind and phosphorylate p130Cas and to colocalize with p130Cas in cell structures that have a pro-invasive function. Moreover, the PKN3-p130Cas interaction is important for mouse embryonic fibroblast growth and invasiveness independent of Src transformation, indicating a mechanism distinct from that previously characterized for p130Cas. Together, our results suggest that the PKN3-p130Cas complex represents an attractive therapeutic target in late-stage malignancies.

Department of Cell Biology Faculty of Science Biocev Charles University Prague 2 Czech Republic

Zobrazit více v PubMed

Aleku M, Schulz P, Keil O, Santel A, Schaeper U, Dieckhoff B, Janke O, Endruschat J, Durieux B, Röder N et al (2008) Atu027, a liposomal small interfering RNA formulation targeting protein kinase N3, inhibits cancer progression. Cancer Res 68, 9788–9798. PubMed

Astier A, Manié SN, Avraham H, Hirai H, Law SF, Zhang Y, Golemis EA, Fu Y, Druker BJ, Haghayeghi N et al (1997) The related adhesion focal tyrosine kinase differentially phosphorylates p130Cas and the Cas‐like protein, p105HEF1. J Biol Chem 272, 19719–19724. PubMed

Brábek J, Constancio SS, Shin NY, Pozzi A, Weaver AM and Hanks SK (2004) CAS promotes invasiveness of Src‐transformed cells. Oncogene 23, 7406–7415. PubMed

Brábek J, Constancio SS, Siesser PF, Shin NY, Pozzi A and Hanks SK (2005) Crk‐associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of Src‐transformed cells. Mol Cancer Res 3, 307–315. PubMed

Braniš J, Pataki C, Spörrer M, Gerum RC, Mainka A, Cermak V, Goldmann WH, Fabry B, Brabek J and Rosel D (2017) The role of focal adhesion anchoring domains of CAS in mechanotransduction. Sci Rep 7, 46233. PubMed PMC

Cabodi S, del Pilar Camacho‐Leal M, Di Stefano P and Defilippi P (2010a) Integrin signalling adaptors: not only figurants in the cancer story. Nat Rev Cancer 10, 858–870. PubMed

Cabodi S, Moro L, Baj G, Smeriglio M, Di Stefano P, Gippone S, Surico N, Silengo L, Turco E, Tarone G et al (2004) p130Cas interacts with estrogen receptor alpha and modulates non‐genomic estrogen signaling in breast cancer cells. J Cell Sci 117, 1603–1611. PubMed

Cabodi S, Tinnirello A, Bisaro B, Tornillo G, del Pilar Camacho‐Leal M, Forni G, Cojoca R, Iezzi M, Amici A, Montani M et al (2010b) p130Cas is an essential transducer element in ErbB2 transformation. FASEB J 24, 3796–3808. PubMed

Cabodi S, Tinnirelo A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G et al (2006) p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2‐Neu oncogene‐dependent breast tumorigenesis. Cancer Res 66, 4672–4680. PubMed

Collazos A, Michael N, Whelan RD, Kelly G, Mellor H, Pang LC, Totty N and Parker PJ (2011) Site recognition and substrate screens for PKN family proteins. Biochem J 438, 535–543. PubMed

Czauderna F, Santel A, Hinz M, Fechtner M, Durieux B, Fisch G, Leenders F, Arnold W, Giese K, Klippel A et al (2003) Inducible shRNA expression for application in a prostate cancer mouse model. Nucleic Acids Res 31, e127. PubMed PMC

Defilippi P, Di Stefano P and Cabodi S (2006) p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol 16, 257–263. PubMed

Donato DM, Ryzhova LM, Meenderink LM, Kaverina I and Hanks SK (2010) Dynamics and mechanism of p130Cas localization to focal adhesions. J Biol Chem 285, 20769–20779. PubMed PMC

Dorssers LC, Grebenchtchikov N, Brinkman A, Look MP, van Broekhoven SP, de Jong D, Peters HA, Portengen H, Meifer‐van Gelder ME, Klijn JG et al (2004) The prognostic value of BCAR1 in patients with primary breast cancer. Clin Cancer Res 10, 6194–6202. PubMed

Dorssers LC, Van der Flier S, Brinkman A, van Agthoven T, Veldscholte J, Berns EM, Kkijn JG, Beex LV and Foekens JA (2001) Tamoxifen resistance in breast cancer: elucidating mechanisms. Drugs 61, 1721–1733. PubMed

Falk MD, Liu W, Bolaños B, Unsal‐Kacmaz K, Klippel A, Grant S, Brooun A and Timofeevski S (2014) Enzyme kinetics and distinct modulation of the protein kinase N family of kinases by lipid activators and small molecule inhibitors. Biosci Rep 34, 93–106. PubMed PMC

Fonseca PM, Shin NY, Brábek J, Rhzhova L, Wu J and Hanks SK (2004) Regulation and localization of CAS substrate domain tyrosine phosphorylation. Cell Signal 16, 621–629. PubMed

Fromont G and Cussenot O (2011) The integrin signalling adaptor p130CAS is also a key player in prostate cancer. Nat Rev Cancer 11, 227. PubMed

Fromont G, Vallancein G, Validire P, Levillain P and Cussenot O (2007) BCAR1 expression in prostate cancer: association with 16q23 LOH status, tumor progression and EGFR/KAI1 staining. Prostate 67, 268–273. PubMed

Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Surner SO, Sun Y, Jacobsen A, Sinha R, Larsson E et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6, pl1. PubMed PMC

Garcia‐Guzman M, Dolfi F, Russello M and Vuori K (1999) Cell adhesion regulates the interaction between the docking protein p130(Cas) and the 14‐3‐3 proteins. J Biol Chem 274, 5762–5768. PubMed

Gemperle J, Hexnerová R, Lepšik M, Tesina P, Dibus M, Novotný M, Brábek J, Veverka V and Rosel D (2017) Structural characterization of CAS SH3 domain selectivity and regulation reveals new CAS interaction partners. Sci Rep 7, 8057. PubMed PMC

Hashimoto T, Mukai H, Kawamata T, Taniguchi T, Ono Y and Tanaka C (1998) Localization of PKN mRNA in the rat brain. Brain Res Mol Brain Res 59, 143–153. PubMed

Heng YW and Koh CG (2010) Actin cytoskeleton dynamics and the cell division cycle. Int J Biochem Cell Biol 42, 1622–1633. PubMed

Hivert V, Pierre J and Raingeaud J (2009) Phosphorylation of human enhancer of filamentation (HEF1) on serine 369 induces its proteasomal degradation. Biochem Pharmacol 78, 1017–1025. PubMed

Honda H, Oda H, Nakamoto T, Honda Z, Sakai R, Suzuki T, Saito T, Nakamura K, Nakao K, Ishikawa T et al (1998) Cardiovascular anomaly, impaired actin bundling and resistance to Src‐induced transformation in mice lacking p130Cas. Nat Genet 19, 361–365. PubMed

Janoštiak R, Brábek J, Auernheimer V, Tatárová Z, Lautscham LA, Dey T, Gemperle J, Merkel R, Goldmann WH, Fabry B et al (2014) CAS directly interacts with vinculin to control mechanosensing and focal adhesion dynamics. Cell Mol Life Sci 71, 727–744. PubMed PMC

Janoštiak R, Tolde O, Brůhová Z, Novotný M, Hanks SK, Rösel D and Brábek J (2011) Tyrosine phosphorylation within the SH3 domain regulates CAS subcellular localization, cell migration, and invasiveness. Mol Biol Cell 22, 4256–4267. PubMed PMC

Kang H, Kim C, Lee H, Rho JG, Seo JW, Nam JW, Song WK, Nam SW, Kim W and Lee EK (2015) Downregulation of microRNA‐362‐3p and microRNA‐329 promotes tumor progression in human breast cancer. Cell Death Differ 23, 484–495. PubMed PMC

Lachmann S, Jevons A, De Rycker M, Cassamassima A, Radtke S, Collazos A and Parker PJ (2011) Regulatory domain selectivity in the cell‐type specific PKN‐dependence of cell migration. PLoS One 6, e21732. PubMed PMC

Leenders F, Möpert K, Schmiedeknecht A, Santel A, Czauderna F, Aleku M, Penschuck S, Dames S, Dternberger M, Röhl T et al (2004) KN3 is required for malignant prostate cell growth downstream of activated PI 3‐kinase. EMBO J 23, 3303–3313. PubMed PMC

Lim WG, Chen X, Liu JP, Tan BJ, Zhou S, Smith A, Lees N, Hou L, Gu F, Yu XY et al (2008) The C‐terminus of PRK2/PKNgamma is required for optimal activation by RhoA in a GTP‐dependent manner. Arch Biochem Biophys 479L, 170–178. PubMed

Makkinje A, Near RI, Infusini G, Vanden Borre P, Bloom A, Cai D, Costello CE and Lerner A (2009) AND‐34/BCAR3 regulates adhesion‐dependent p130Cas serine phosphorylation and breast cancer cell growth pattern. Cell Signal 21, 1423–1435. PubMed PMC

Mellor H, Flynn P, Nobes CD, Hall A and Parker PJ (1998) PRK1 is targeted to endosomes by the small GTPase, RhoB. J Biol Chem 273, 4811–4814. PubMed

Möpert K, Löffler K, Röder N, Kaufmann J and Santel A (2012) Depletion of protein kinase N3 (PKN3) impairs actin and adherens junctions dynamics and attenuates endothelial cell activation. Eur J Cell Biol 91, 694–705. PubMed

Mukai H, Muramatsu A, Mashud R, Kubouchi K, Tsujimoto S, Hongu T, Kanaho Y, Tsubaki M, Nishida S, Shiol G et al (2016) PKN3 is the major regulator of angiogenesis and tumor metastasis in mice. Sci Rep 6, 18979. PubMed PMC

Mukai H and Ono Y (1994) A novel protein kinase with leucine zipper‐like sequences: its catalytic domain is highly homologous to that of protein kinase C. Biochem Biophys Res Commun 199, 897–904. PubMed

Nagai Y, Osawa K, Fukushima H, Tamura Y, Aoki K, Ohya K, Yasuda H, Hikiji H, Takahashi M, Seta Y et al (2013) p130Cas, Crk‐associated substrate, plays important roles in osteoclastic bone resorption. J Bone Miner Res 28, 2449–2462. PubMed

Nick AM, Stone RL, Armaiz‐Pena G, Ozpolat B, Tekedereli I, Graybill WS, Landen CN, Villares G, Vivas‐Mejia P, Bottsford‐Miller J et al (2011) Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death. J Natl Cancer Inst 103, 1596–1612. PubMed PMC

Nikonova AS, Gaponova AV, Kudinov AE and Golemis EA (2014) CAS proteins in health and disease: an update. IUBMB Life 66, 387–395. PubMed PMC

Oishi K, Mukai H, Shibata H, Takahashi M and Ona Y (1999) Identification and characterization of PKNbeta, a novel isoform of protein kinase PKN: expression and arachidonic acid dependency are different from those of PKNalpha. Biochem Biophys Res Commun 261, 808–814. PubMed

Piccinini F, Kiss A and Horvath P (2015) Cell Tracker (not only) for dummies. Bioinformatics 32, 955–957. PubMed

Pylayeva Y, Gillen KM, Gerald W, Beggs HE, Reichardt LF and Giancotti FG (2009) Ras‐ and PI3K‐dependent breast tumorigenesis in mice and humans requires focal adhesion kinase signaling. J Clin Invest 119, 252–266. PubMed PMC

Quilliam LA, Lambert QT, Mickelson‐Young L, Westwick JK, Sparks AB, Kay BK, Jenkins NA, Gilbert DJ, Copeland NG and Der CJ (1996) Isolation of a NCK‐associated kinase, PRK2, an SH3‐binding protein and potential effector of Rho protein signaling. J Biol Chem 271, 28772–28776. PubMed

Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA and Zhang F (2013) Genome engineering using the CRISPR‐Cas9 system. Nat Protoc 8, 2281–2308. PubMed PMC

Riedl J, Crevenna AH, Kessenbrock K, Yu JH, Neukirchen D, Bista M, Bradke F, Jenne D, Holak TA, Werb Z et al (2008) Lifeact: a versatile marker to visualize F‐actin. Nat Methods 5, 605–607. PubMed PMC

Ruest PJ, Shin NY, Polte TR, Zhang X and Hanks SK (2001) Mechanisms of CAS substrate domain tyrosine phosphorylation by FAK and Src. Mol Cell Biol 21, 7641–7652. PubMed PMC

Santel A, Aleku M, Röder N, Möpert K, Durieux B, Janke O, Keil O, Endruschat J, Dames S, Lange C et al (2010) Atu027 prevents pulmonary metastasis in experimental and spontaneous mouse metastasis models. Clin Cancer Res 16, 5469–5480. PubMed

Schindelin J, Arganda‐Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, Rueden C, Saalfeld S, Schmid B, Tinevez JY et al (2012) Fiji: an open‐source platform for biological‐image analysis. Nat Methods 9, 676–682. PubMed PMC

Schultheis B, Strumberg D, Santel A, Vank C, Gebhardt F, Keil O, Lange C, Giese K, Kaufmann J, Khan M et al (2014) First‐in‐human phase I study of the liposomal RNA interference therapeutic Atu027 in patients with advanced solid tumors. J Clin Oncol 32, 4141–4148. PubMed

Strumberg D, Schultheis B, Traugott U, Vank C, Santel A, Keil O, Giese K, Kaufmann J and Drevs J (2012) Phase I clinical development of Atu027, a siRNA formulation targeting PKN3 in patients with advanced solid tumors. Int J Clin Pharmacol Ther 50, 76–78. PubMed

Ta HQ, Thomas KS, Schrecengost RS and Bouton AH (2008) A novel association between p130Cas and resistance to the chemotherapeutic drug adriamycin in human breast cancer cells. Cancer Res 68, 8796–8804. PubMed PMC

Tarone G, Cirillo D, Giancotti FG, Cornoglio PM and Marchisio PC (1985) Rous sarcoma virus‐transformed fibroblasts adhere primarily at discrete protrusions of the ventral membrane called podosomes. Exp Cell Res 159, 141–157. PubMed

Tazaki T, Miyazaki K, Hiyama E, Nakamoto T, Sakai R, Yamasaki N, Honda Z, Noda M, Miyasaka N, Sueda T et al (2008) Functional analysis of Src homology 3‐encoding exon (exon 2) of p130Cas in primary fibroblasts derived from exon 2‐specific knockout mice. Genes Cells 13, 145–157. PubMed

Tikhmyanova N, Little JL and Golemis EA (2010) CAS proteins in normal and pathological cell growth control. Cell Mol Life Sci 67, 1025–1048. PubMed PMC

Tornillo G, Defilippi P and Cabodi S (2014) Cas proteins: dodgy scaffolding in breast cancer. Breast Cancer Res 16, 443. PubMed PMC

Uehara S, Udagawa N, Mukai H, Ishihara A, Maeda K, Yamashita T, Murakami K, Nishita M, Nakamura T, Kato S et al (2017) Protein kinase N3 promotes bone resorption by osteoclasts in response to Wnt5a‐Ror2 signaling. Sci Signal 10, eaan0023. PubMed

Unsal‐Kacmaz K, Ragunathan S, Rosfjord E, Dann S, Upeslacis E, Grillo M, Hernandez R, Mack F and Klippel A (2012) The interaction of PKN3 with RhoC promotes malignant growth. Mol Oncol 6, 284–298. PubMed PMC

Van Troys M, Masuzzo P, Huyck L, Bakkali K, Waterschoot D, Martens L and Ampe C (2018) Analysis of invasion dynamics of matrix‐embedded cells in a multisample format. Methods Mol Biol 1749, 79–117. PubMed

Vincent S, Settleman J (1997) The PRK2 kinase is a potential effector target of both Rho and Rac GTPases and regulates actin cytoskeletal organization. Mol Cell Biol 17, 2247–2256. PubMed PMC

Yamakita Y, Totsukawa G, Yamashiro S, Fry D, Zhang X, Hanks SK and Matsumura F (1999) Dissociation of FAK/p130(CAS)/c‐Src complex during mitosis: role of mitosis‐specific serine phosphorylation of FAK. J Cell Biol 144, 315–324. PubMed PMC

A Screen for PKN3 Substrates Reveals an Activating Phosphorylation of ARHGAP18

Zobrazit více v PubMed

GENBANK
SB202190